Skip to main content
. 2019 Aug;16(3):542–555. doi: 10.20892/j.issn.2095-3941.2018.0407

4.

4

HS activates PKCa-ERK1/2-FRA-1 cascade. (A) Western blot measurement of ERK1/2, FRA-1 and PKCa phosphorylation in HS-treated CRC cells. (B) PKC activity measurement of CT-26 and SW620 cells after HS treatment for 5 days. (C) Western blot analysis of p-ERK1/2, p-FRA-1 and p-PKCa expression in control, HS-treated CT-26 and SW620 cells in the presence or absence of U0126, Gö6976 or FRA-1 siRNA. C: control, G: Gö6976, U: U0126. The quantification value was labeled above the bands. All data were from three independent experiments.